Clinical Trial Update: Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating chemotherapy and peripheral blood stem cell transplant followed by Aldesleukin and Sargramostim in inflammatory Stage IIIB or metastati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Inflammatory Breast Cancer
• Stage Iiib Breast Cancer

Drugs mentioned

• Aldesleukin (interleukin-2)
• sargramostim (sargramostim)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-05-17